Aer Therapeutics announced it raised $3 Million in an initial filing from an offering of $3 Million
PRIVATEAug 19, 2026•about 4 hours ago
Amount Raised
$3 Million
Round Type
Seed
RaleighBiotechnology
Company Information
Company
Aer Therapeutics
Location
400 W NORTH STREET
Raleigh, North Carolina, United States
About
Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs. We are focused on treating respiratory diseases with significant unmet need, such as COPD, cystic fibrosis and asthma.
Our technology was developed and spun out of Dr. John Fahy’s airway biology lab at University of California San Francisco (UCSF) in collaboration with Dr. Stefan Oscarson’s glycochemistry lab at University College Dublin and Dr. Anne Marie Healy’s pharmaceutics lab at Trinity College Dublin. The efforts of this research consortium led to over $18M in NIH grant funding, resulting in the identification of our lead therapeutic candidate (AER-01), establishment of preliminary safety and efficacy profiles, and the production of clinical trial API.
Don't miss Aer Therapeutics's next move
Get an email the moment Aer Therapeutics raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
2 contacts
Verified contactsJohn F., Director
Predictive Intelligence
Strategic
ML-powered predictions for Aer Therapeutics's next move
RaleighBiotechnology